In the chart below, you can see how the company has grown earnings and revenue, over time. For finer detail, click on the image. Fortunately, we've got access to analyst forecasts of Cohort's ...

(NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity.

Cohort is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share indices. Cohort is listed in the Aerospace sector. Cohort Plc Ord 10p is listed on the London Stock Exchange trading with ...